Compare Medpace Holdings Inc (MEDP) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Value Index Fund ETF — how do they compare? Medpace Holdings Inc trades at $530.31 (market cap $15.08B), while Vanguard Value Index Fund ETF trades at $218.11. The key difference: Vanguard Value Index Fund ETF is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | VTV | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | — |
52-Week High | $620.59 | $220.51 |
52-Week Low | $308.88 | $175.51 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
VTV trades at $216.94, down 0.45% on the day, with a neutral technical signal and bullish moving averages. Recent news highlights its role as a stability-focused ETF amid AI sector volatility, with a 16% year-to-date gain. The fund's low expense ratio and value-oriented portfolio attract investors rotating away from tech.
The outlook for VTV hinges on continued value stock outperformance and Federal Reserve policy. Risks include inflation sensitivity and tech sector rebounds. Analyst sentiment is balanced, with the ETF positioned for defensive growth but vulnerable to macroeconomic shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
